Galapagos NV Stock Predictions
Trading levels for GLPG
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 35.72 | 1.29 % | |
R2 | 35.51 | 0.690 % | ||
R1 | 35.38 | 0.322 % | ||
Current price: | 35.27 | |||
Support | S1 | 34.96 | -0.87 % | |
S2 | 34.83 | -1.24 % | ||
S3 | 34.62 | -1.83 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 40.43 | 14.63 % | |
R2 | 38.99 | 10.55 % | ||
R1 | 38.84 | 10.12 % | ||
Current price | 35.27 | |||
Support | S1 | 35.16 | -0.312% | |
S2 | 0 | . | ||
S3 | 0 | . |
GLPG Predictions History
3 years ago
sander7100 yo bro predicted that
GLPG
for 2020-08-21 is going
$192.15 (40.09%)
4 years ago
GoldenNugget predicted that
GLPG
for 2019-05-07 is going
$120.26 (4.76%)
4 years ago
GoldenNugget predicted that
GLPG
for 2019-05-06 is going
$108.22 (-5.86%)
4 years ago
NameNotImportant predicted that
GLPG
for 2019-04-23 is going
$113.69 (-1.14%)
4 years ago
PumpTheseNumbers predicted that
GLPG
for 2019-04-03 is going
$118.14 (-3.56%)
4 years ago
Mars.Wong.104328 predicted that
GLPG
for 2019-04-03 is going
$110.11 (-10.11%)
6 years ago
Joost.Piepers.9742 predicted that
GLPG
for 2017-07-20 is going
$74.00 (-2.84%)
About Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.